Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: question - any serious answers. please

Prior to PTSC buying and retiring S&L's warrants, S&L converted many of their warrants which caused the dilution. Yes, PTSC did buy back shares, just not enough to offset the amount of warrants converted.

 

GLTA LOngs................Go PTSC!!!!!!!!!!!!!!!

Share
New Message
Please login to post a reply